Why Poland
Home > Why Poland > Sectors > MedTech

MedTech SectorMedTech Sector

Large, fast-growing domestic market

  • Large, aging population - 38.3m
  • Largest CEE market for medical devices - USD 11bn, forecasted to reach USD 13.8bn in 2024
  • Growing private healthcare sector - 7% CAGR in years 2016-2021
  • Highest health expenditure in CEE - USD 38.2bn
  • Market growing at 10.1% CAGR 2019-2024 in USD terms - 2x the Global CAGR
  • 6,2% of GDP spent on healthcare going up to 7% by 2027 according to the Government’s policy
Sources: GUS; OECD data, Q3 2020; PMR; MedTech Europe Report 2020; Fitch Solutions MedTech Industry Report

Attractive MedTech hub
  • EU membership
    EU member since 2004 with strong links to eurozone, ensuring same pharmaceutical quality standards
  • Most resilient to COVID crisis in the EU
    The Polish economy reported the smallest drop in GDP dynamics among EU countries
  • Fast exports growth
    Growing MedTech services and production, with exports increasing by 18.9% in 2018
  • 4th largest talent pool in EU
    Availability of highly skilled employees, large and well educated labour force
  • Fast-growing domestic companies
    Revenues of domestic companies increased by 30% between 2014 and 2018
  • >80% of transport by rail between China-EU runs through Poland
    Logistics bridge between the East and the West, proximity to many markets

Sources: OECD statistics; Press research; Puls Biznesu and Spotdata Report “Polish MedTech - chances and illusions”; Bloomberg; InfoCredit

Innovation booster

  • Regulations in line with EU legislation
  • Governmental incentives for R&D
  • Large MedTech pool of graduates
  • 11 million patient research base annually
  • Fast growth of R&D centers, 300+ over the past few years
  • Synergies with important IT industry

"Poland has an immense pool of talent and is a hotbed for innovation that continues to grow."

"Poland’s overlapping business hours with all of our R&D centres around the world definitely facilitates flawless global operations."

Frank Konings, COO, Johnson & Johnson

Sources: GUS; OECD statistics; Press research; Puls Biznesu and Spotdata Report “Polish MedTech - chances and illusions”; jnjpoland.pl

Dynamic MedTech environment
  • CRO R&D
    Total CRO: 50
    Paraxel, ICON, Novartis, PRA, PSI, Roche, Pfizer
  • Startups
    Around 100 MedTech startups
    Among others - StethoMe, Pregnabit, MedApp
  • Universities
    + 64 thousand medical students each year
    Dedicated MedTech studies: 3D Technologies in Medicine, Biocybernetics, Bioengineering, Neuroinformatics, IT in Medicine&Pharma
Sources: Crido Report “R&D market in Poland”; badaniaklinicznewpolsce.pl; laboratoria.net

Return »

Polish Investment and Trade Agency

Krucza St. 50

00-025 Warsaw

All rights reserved. Legal disclaimer

This website uses cookies. Use of this site constitutes agreement to the record or use.
For more information, see our Privacy Policy. I accept the Privacy Policy zamknij